pylclari
curium pet france - piflufolastat (18f) - eesnäärmevähk - diagnostilised radiofarmatseutilised ühendid - see ravim on mõeldud ainult diagnostiliseks kasutamiseks. pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent. pylclari is indicated for use with positron emission tomography (pet).
spiriva inhalatsioonipulber kõvakapslis
boehringer ingelheim international gmbh - tiotroopium - inhalatsioonipulber kõvakapslis - 18mcg 90tk; 18mcg 300tk; 18mcg 10tk; 18mcg 60tk; 18mcg 150tk
kreon 35 000 u gastroresistentne kõvakapsel
viatris healthcare limited - lipaas+amülaas+proteaas - gastroresistentne kõvakapsel - 35000ühik+25200ühik+1400ühik 60tk; 35000ühik+25200ühik+1400ühik 200tk; 35000ühik+25200ühik+1400ühik 120tk; 35000ühik+25200ühik+1400ühik 100tk; 35000ühik+25200ühik+1400ühik 50tk
kreon 20 000 u gastroresistentne kõvakapsel
viatris healthcare limited - lipaas+amülaas+proteaas - gastroresistentne kõvakapsel - 20000ühik+16000ühik+1200ühik 120tk; 20000ühik+16000ühik+1200ühik 100tk; 20000ühik+16000ühik+1200ühik 60tk; 20000ühik+16000ühik+1200ühik 50tk
delipid plus kõvakapsel
egis pharmaceuticals plc - rosuvastatiin+esetimiib - kõvakapsel - 40mg+10mg 30tk; 40mg+10mg 56tk; 40mg+10mg 7tk; 40mg+10mg 90tk; 40mg+10mg 10tk; 40mg+10mg 60tk
delipid plus kõvakapsel
egis pharmaceuticals plc - rosuvastatiin+esetimiib - kõvakapsel - 20mg+10mg 56tk; 20mg+10mg 7tk; 20mg+10mg 60tk; 20mg+10mg 84tk; 20mg+10mg 10tk; 20mg+10mg 90tk
delipid plus kõvakapsel
egis pharmaceuticals plc - rosuvastatiin+esetimiib - kõvakapsel - 10mg+10mg 7tk; 10mg+10mg 60tk; 10mg+10mg 30tk; 10mg+10mg 90tk; 10mg+10mg 28tk; 10mg+10mg 10tk
physioneal 40 clear-flex glucose 22,7 mg/ml peritoneaaldialüüsilahus
oÜ baxter estonia - hüpertoonilised lahused - peritoneaaldialüüsilahus - 2,27% 1500ml 5tk; 2,27% 3000ml 3tk; 2,27% 1500ml 6tk; 2,27% 2000ml 5tk; 2,27% 2500ml 3tk; 2,27% 2500ml 4tk
physioneal 40 clear-flex glucose 38,6 mg/ml peritoneaaldialüüsilahus
oÜ baxter estonia - hüpertoonilised lahused - peritoneaaldialüüsilahus - 3,86% 2500ml 3tk; 3,86% 4500ml 2tk; 3,86% 2000ml 4tk; 3,86% 5000ml 2tk; 3,86% 1500ml 6tk
physioneal 35 clear-flex glucose 38,6 mg/ml peritoneaaldialüüsilahus
oÜ baxter estonia - hüpertoonilised lahused - peritoneaaldialüüsilahus - 3,86% 2500ml 4tk; 3,86% 2000ml 5tk; 3,86% 3000ml 3tk